Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rejoni
AddedFeb 17, 2024
UpdatedJun 18, 2026
Rejoni

Rejoni

Series B

Rejoni: Innovating women's health technology to minimize risks in gynecological procedures.

HQ
Bedford, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Rejoni was founded with the mission to innovate women's health technology, specifically focusing on minimizing the risks associated with gynecological procedures. The company's vision is to provide women with health-centered technologies that enable them to lead healthier lives both now and in the future. Rejoni offers solutions aimed at reducing both acute and chronic risks in gynecologic procedures, including products designed to prevent intrauterine adhesions and fibroids.

Notable affiliated individuals and investors have not been publicly disclosed. However, Rejoni's key achievements include the development of cutting-edge technologies and the initiation of clinical trials, such as the JUVEENA™ clinical study, which evaluates new products aimed at preventing intrauterine adhesions and fibroids. The overall impact of Rejoni's innovations is significant in advancing women's health by providing safer and more effective gynecological treatments.

Rejoni - Similar Companies

Rijuven logo

Rijuven

rijuven.com

Juvent - Regenerative Technologies logo

Juvent - Regenerative Technologies

juvent.com

Minerva Surgical logo

Minerva Surgical

Rinovum Women's Health logo

Rinovum Women's Health

Rebion logo

Rebion

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

Gynesonics logo

Gynesonics

gynesonics.com

Equani logo

Equani

Ciconia Medical logo

Ciconia Medical

ciconiamedical.com

NextGen Jane logo

NextGen Jane

nextgenjane.com

Avana Health logo

Avana Health

avana.health

Bioceptive logo

Bioceptive

bioceptive.com

Novogiene logo

Novogiene

RBI Medical logo

RBI Medical

ReQbo logo

ReQbo

Rejoni - Quick Facts

Who are Rejoni's competitors?

Companies similar to Rejoni include Rijuven, Juvent - Regenerative Technologies, Minerva Surgical and Rinovum Women's Health.

When was Rejoni founded?

Rejoni was founded in 2020.

Where is Rejoni's headquarters located?

Rejoni's headquarters is located in Bedford, MA, US.

When was Rejoni's last funding round?

Rejoni's most recent funding round was for $26.3M (USD) in December 2022.

How much has Rejoni raised to-date?

As of Dec 7, 2022, Rejoni has raised a total of $41.3M (USD).

How many employees does Rejoni have?

Rejoni has 15 employees as of Feb 5, 2024.

Rejoni - Classification

Industry
  • Hardware
Technology
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified